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Summary
Introduction: The young age of patients, total arthroplasties complications risks, and implant
costs justify evaluation of the results of core decompression in the treatment of sickle-cell
disease avascular necrosis of the femoral head (ONFH).
Hypothesis: In sickle-cell disease necrosis, core decompression offers good relief from pain and
delays the use of total arthroplasty in comparison to a conservatively treated control group by
a simple non-weight bearing protocol.
Materials and Methods: From 1994 to 2008, among 215 drepanocytic adults, 42 patients
(22 genotype SS, 20 genotype SC; 15men, 27women) presented symptomatic ONFH. We report
the data from a prospective study of two patients’ groups: a non-operated group (16 patients
aged 36.5± 6.5 years, 23 hips) and an operated group (26 patients aged 30.3± 2.8 years,
42 hips). The results were considered on the basis of change in clinical status according to
the numeric evaluation of pain scale, the functional score of Merle d’Aubigné-Postel (MAP), the
radiological progression of lesions, and the time delay to total arthroplasty.
Results: Twenty-three hips were conservatively treated by discharge (a pair of canes). After a
follow-up period of 13.4± 0.5 years, no pain improvement was noted (p = 0.76), and MAP score
was unchanged (p = 0.27). Out of 23 hips managed by discharge, 9 stage IV hips (degenerative
arthritis, 39.1%) underwent arthroplasty after an average delay of 2.6± 2.4 years.
Forty-two hips were treated by core decompression. The duration of follow-up was
11.3± 1.8 years. Postoperatively, pain reduction and MAP score improvement were signiﬁcant
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in 39 out of 42 hips (93%, p < 0.0001). Twenty-nine out of these 42 hips had a favorable evolution.
Ten hips (23.8%) progressed to total arthroplasty, after a period of 7.4± 2.7 years, longer than
the one of the non-operated group (p = 0.0007).
By comparing the two groups (operated and non-operated), the beneﬁt of core decompression
appeared very signiﬁcant (p < 0.0001). In addition to allocating Patients osteonecrosis stages,
the Koo and Kim Index estimated the severity and evolution of necrotic lesions in both groups. It
indicated decline in the non-operated group (p = 0.002) and improvement for operated patients
(p = 0.0002).
Discussion: Core decompression had a favorable clinical and radiological outcome superior to
surgical abstention. Stages I and II ONFH remained stable after drilling, necessitating no arthro-
plasty (considered as a failure of drilling). The Koo and Kim Index above 30◦ in the non-operated
group was a signiﬁcant indicator of lesions degradation (p = 0.002). In addition to the indolence
obtained by core decompression, the beneﬁt of drilling was manifested by the prolonging the
adjournment before arthroplasty end-point. It was respectively 7.4± 2.7 years in the operated
group versus 2.6± 2.4 years in the non-operated group (difference of 4.8 years, p < 0.01).
Conclusion: The technique of core decompression remains a valid option place in the treatment
sickle-cell disease avascular necrosis of the femoral head (ONFH). It may be especially recom-
mended in under-equipped regions where drepanocytosis and its osteo-articular complications
are frequent.
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Introduction
Drepanocytosis remains the leading cause of osteonecrosis
of the femoral head (ONFH) in high-risk regions. Its fre-
quency varies between 30 and 40% in adolescent or adult
drepanocytic patients [1—3]. The unpredictable evolution
of ONFH lesions conducts orthopaedic surgeons living in
these regions to optimize preventive and therapeutic care.
Without treatment, ONFH evolves towards arthrosic seque-
lae that are difﬁcult to control. These joint complications
appear at a very young age [1,4].
Treated early, ONFH lesions in sickle cell anemia patients
may be reversible and evolve towards healing [5]. The liter-
ature reports therapies ranging from medical interventions,
associated or not with discharge, to the surgical approach,
i.e. core decompression in an early stage (simple drilling
or associated with bone marrow or osteoinducing protein
injection) or osteotomy [6—9]. These drepanocytic patients
cannot support the heavy burden of surgical interventions
and are sensitive to infections. The uncertain outcome
of orthopaedic treatments and mechanical or infectious
complications of total arthroplasties in adults as well as
implant-prostheses costs [10,11] justify the evaluation of
simple drilling in the approach to ONFH. Our prospective
working hypothesis was that core decompression was bet-
ter in controlling pain and slowing the use of total hip
arthroplasty relative to a control group treated by simple
discharge.
Materials and methods
PatientsFrom 1994 to 2008, out of 215 drepanocytic adults
at the Caribbean drepanocytosis centre (Pointe-à-Pitre
UHC), 42 patients (22 genotype SS, 20 genotype SC; 15men,
27women, aged over 16 years) were symptomatic carriers
[
•-control therapeutic study.
sson SAS.
f ONFH evolving to stages I, II or III (with sub-chondral dis-
ection) according to the classiﬁcation of Arlet et al. [12],
dapted for modern imaging [13].
All patients in this series presented hip pain. A sup-
lementary report included bone scintigraphy, simple
omography, tomodensitometry (TDM) or magnetic reso-
ance imaging (MRI) [1,3,6,7]. Evolution of the lesions was
tudied by repetition of MRI and TDM at 6weeks. The
atients were divided into two groups:
16 non-operated patients, who refused surgery or pre-
sented a poor general state with numerous crises,
pulmonary arterial hypertension, renal failure, skin
ulcers (infectious risk) or immediate post-partum. These
16 patients (23 hips) were treated by temporary discharge
during 2 to 3months;
26 surgery patients, who underwent simple drilling
(42 hips). Preoperative preparation was completed in
consultation with physicians, anaesthetists and medical
specialists in sickle cell disease.
valuation of the clinical results
linical signs reminiscent of drepanocytic ONFH were char-
cterized by pain, caused especially by internal hip rotation,
ameness, associated or not with limitation of joint mobility.
ain intensity was evaluated on a numeric pain evaluation
cale (NPS): 0 (minimal) to 100 (maximal). The assessment
f pain in hyperalgic patients was difﬁcult, as some of them
ended to under-evaluate or over-evaluate their pain. To
ake the NPS more reliable, it was necessary to correlate
ain with taking antalgics according to three levels (lev-
ls I, IIa, IIb, III) to ascertain pain intensity more precisely
14,15]:
level I: non-opioid peripheral antalgics (paracetamol;
anti-inﬂammatory agents);
5 M. Mukisi-Mukaza et al.
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Figure 1 Material required for drilling (top to bottom): 1.
Graft remover, 2. Tightening and untightening wrench of the
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level II: weak (IIa) or average (IIb) central opioid antalgics;
level III: strong central opioids (morphinic).
The results were based on the evaluation of pain intensity
NPS), deﬁned by grade 1 (no pain), grade 2 (less than 50 on
he NPS, moderate pain relieved by level I or IIa antalgics),
r grade 3 (more than 50 on the NPS, intense pain relieved by
evel IIb and III painkillers). Pain was assessed before treat-
ent (discharge or drilling) and 6weeks after treatment.
oint function was evaluated by the Merle d’Aubigné-Postel
PMA) score at 1 year [16].
valuation of the radiological results
NFH was assessed by non-invasive techniques based on an
lgorithm deﬁned in our centre: standard radiology, tech-
etium 99m diphosphonate bone scintigraphy, TDM and MRI
3,17,18]. Drepanocytic ONFH was classiﬁed according to
rlet et al. [12] adapted to modern imaging [13]. Baseline
nterior-posterior and lateral view examination highlighted
hanges in joint pattern, sphericity and congruence (with-
ut revealing stage I lesions by preradiological deﬁnition).
DM could show evolutive lesions despite the frequent pres-
nce of sclerotic images in stage II drepanocytosis. It allowed
s to distinguish the seriousness of three types of stage
II lesions: sub-chondral dissection, uni- or bipolar rupture
ithout loss of sphericity, bipolar rupture with depression
nd deﬁnitive loss of sphericity of the femoral head. Heal-
ng was characterized by non-evolutive images of sclerosis
r osteocondensation. MRI, according to the Index of Koo
nd Kim [19], permitted us to calculate the extent of the
ecrotic zone considered by criteria of severity. We studied
wo groups of lesions: group 1 (Koo and Kim Index of 0—30◦)
nd group 2 (Koo and Kim Index above 30◦).
perating technique
he classic auger of Ficat and Grijalvo [20] as well as the
azabraud trocar [9] were not used, because of cortical
ardness at the point of introduction in the trochanteric
ass and femoral head sclerosis in drepanocytic patients.
speciﬁc stainless steel auger (Carpenter 455) with an
xternal diameter of 8mm was developed by our Division
n collaboration with the GEXFIX® Company (Switzerland).
his is a hollow modular trocar with two parts: one that
uts 80mm with lateral windows and possible extensions of
0, 80 or 100mm. A tightening wrench to separate the auger
rom its extender and a graft-remover allow the extraction
f core biopsy specimens for histological study (Fig. 1).
Drilling-biopsy was performed by the same operator, fol-
owing the technique of Ficat and Grijalvo [20], on an
rthopaedic table, in the supine position, under image
ntensiﬁer control assuring anterior-posterior and lateral
iews of the hip. Drilling was transcutaneous, using the
MN-GEXFIX® auger mounted on a motor. It allowed 8-mm
ervico-cephalic drilling and the collection of core biopsy
pecimens 6mm in diameter. This unique sub-chondral drill
espected the integrity of cephalic cartilage. Surgery was
erformed under general or epidural anaesthesia. Bilateral
rilling could be undertaken during the same intervention.
wenty-four-hour drainage, mobilization and early respira-
s
i
t
i
fuger to the extender, 3. 8-mm diameter and 100-mm long
MN-GEXFIX® auger. 4-6. Hollow extenders of 100, 80 or 40mm
vailable.
ory kinesitherapy, anti-thrombotic treatment and a 6-week
on-weight-bearing period were prescribed.
tatistics
e compared averages, according to the formula described
y Schwartz [21]:  = (MA—MB)/(SA2/NA + SB2/NB)½ where SA2
nd SB2 designated estimated variances (the difference was
igniﬁcant if ≥ 1.96). We used the Chi2 test to control the
ndependence of two characteristics in the two study popu-
ations, the non-operated group and the operated group. p
alues were directly provided by EXCEL® (p < 0.05 indicating
igniﬁcant differences).
esults
he two groups were statistically comparable (age, sex, uni-
r bilateral lesions, lesion stages, time to diagnosis and dura-
ion of follow-up (Table 1).
Sixteen drepanocytic patients (23 hips) were not oper-
ted: eight genotype SS (50%), eight genotype SC (50%, NS);
ve men (31.2%), 11women (68.8%, NS); seven bilateral
esions (43.8%), nine unilateral (56.2%, NS). Average age
as 36.5± 6.5 years. They presented 23 affected hips: ﬁve
n stage I, 12 in stage II, and six in stage III. Time to diagno-
is was 2.5± 0.5months, and the duration of follow-up was
3.4± 0.5 years.
Twenty-six drepanocytic patients (42 hips) were oper-
ted: 14 genotype SS (53.8%), 12 genotype SC (46.2%, NS);
0men (38.5%) and 16women (61.5%, NS) were treated
or persistent hip pain due to evolutive lesions on imag-
ng, which was repeated at least twice. Fifteen lesions
ere bilateral (57.7%), 12 unilateral (52.3%, NS). Average
atient age was 30.3± 2.8 years. We observed 10 hips in
tage I, 13 in stage II, and 19 in stage III. Among all hips
n different stages, the time period between diagnosis and
reatment was 6± 2 months. Average length of hospital-
zation was 5 days (maximum 6, minimum 4), and patient
ollow-up duration was 11.3± 1.8 years. In comparing the
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Table 1 Study population, time to diagnosis and follow-up.
Non-operated (N = 16) Core decompression (N = 26) p value
Age 36.5± 6.5 years 30.3± 2.8 years NS
Men 5 (31.2%) 10 (38.5%) NS
Women 11 (68.8%) 16 (61.5%) NS
Genotype SS 8 (50%) 14 (53.8%) NS
Genotype SC 8 (50%) 12 (46.2%) NS
Bilateral 7 (43.8) 15 (57.7%) NS
Unilateral 9 (56.2) 12 (52.3%) NS
Time to diagnosis 2.5± 0.5months 6± 2months < 0.001
11.3± 1.8 years NS
15 (57.7%) 0.02
3 (60%) deteriorated towards stage III; b) among 12 hips in
stage II, 3 (25%) were stable, 6 (50%) degenerated to stage
III and 3 (25%) to stage IV; c) all 6 hips in stage III dete-
riorated to stage IV (Fig. 2A and B). In the non-operated
group, lesion evolution was favorable in 5 out of 23 hips
(21.7%). The Chi-square test showed no improvement after
conservative treatment (p = 0.26). Nine hips (39.1%) in stage
IV underwent arthroplasty after 2.6± 2.4 years.
In the group of 42 hips treated by drilling, presenting
painful and evolutive necrosis, 10 (23.8%) were in stage I, 13
(31%) in stage II, and 19 (45.2%) in stage III. In all stages com-
bined, the time to diagnosis was 6± 2 months. The evolution
of these lesions was: a) all 10 hips in stage I were unchanged
and stable; b) all 13 hips in stage II were unchanged and sta-
ble; c) among 19 hips in stage III, 2 (10.5%) improved, 4 (21%)
stayed in the same stage, and 13 (68.4%) evolved towards
arthrosis, i.e. stage IV (Fig. 3A, B, C). Twenty-nine out of
42 hips evolved favorably, the beneﬁt from drilling being
signiﬁcant (p < 0.0001). Ten arthrosic hips (23.8%) were re-Follow-up duration 13.4± 0.5 years
Very satisﬁed or satisﬁed 16 (18.7%)
two groups, the difference in time to diagnosis was shorter
in the non-operated group (2.5± 0.5months) than in the
operated group (6± 2months, p < 0.001).
Pain evaluation
In the group of 23 non-operated hips before discharge, pain
was quantiﬁed as grade 2 in 15 hips (65.2%) and grade 3 in
eight hips (34.8%). After discharge, it persisted as grade 2
in 14 hips (60.9%) and as grade 3 in nine hips (39.1%). No
improvement was observed, necessitating level IIb and III
antalgics (p = 0.76).
Among the 42 operated hips, pain was scored as grade
2 in 24 hips (57.1), and grade 3 in 18 hips (42.9%), before
drilling. After drilling, it was rated as grade 1 (no pain) in
28 hips (66.7%), grade 2 in 11 hips (26.2%), and grade 3 in
three hips (7.1%). In all stages combined, the decrease in
postoperative pain was constant, ranging from indolence to
moderate pain in 39 out of 42 hips (92.8%), requiring level I
or IIa antalgics (93%, p < 0.0001).
Evaluation of MAP score
In the absence of surgical support, in 23 hips, the MAP score
was improved in eight hips at 1 year (34.8%), nine hips at
three years (39.1%, going from 15 to 18). The score remained
‘‘fair to poor’’ (14 to <9) in 15 hips at 1 year (65.2%) and
in 14 hips at 3 years (60.8%). It was statistically unchanged
between evaluation before and after conservative treat-
ment, at 1 or 3 years (p = 0.27).
After drilling, assessment of the MAP score in 42 hips
revealed stabilization, showing improvement of joint func-
tion, scoring 15 to 18 (very good to good) at 1 year in 28
hips (66.7%) with degradation (14 to < 9) in 14 hips (33.3%).
At 3 years, 30 hips (71.4%) had a score of 15 to 18, 12 hips
(28.6%) had a score of 14 to less than 9. Improvement was
statistically very signiﬁcant after drilling and throughout
follow-up (p < 0.0001).
Evolution of necrotic lesionsIn the group treated by discharge (23 hips): 5 (21.7%) were
in stage I, 12 (52.2%) in stage II, and 6 (26.1%) in stage III.
The time to diagnosis was 2.5± 0.5 months. Lesion evolu-
tion was: a) among 5 hips in stage I, 2 (40%) were stable and
Figure 2 Patient with genotype SS aged 21 years, left stage III
ONFH treated by discharge (A). Unfavorable evolution towards
subluxation osteoarthrosis at 3 years of follow-up (B).
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Figure 3 Patient with genotype SS aged 26 years with bilateral stage III ONFH and unilateral rupture (2A), evolution after
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perated, by uni- or bilateral arthroplasty after 7.4± 2.7
ears.
valuation according to the Koo and Kim Index
n addition to ONFH staging, the Index of Koo and Kim [19]
valuated the severity and evolution of necrotic lesions in
oth patient groups. In the non-operated group, it was cal-
ulated by grouping stages I—II and III—IV during diagnosis.
t was below 30◦ in 12 hips in stages I—II (52.3%) and in 1 hip
n stages III—IV (4.3%); it was above 30◦ in ﬁve hips in stages
—II (21.7%) and in 5 other hips in stages III or IV (21.7%)
In the operated group, in stages I—II, the index was below
0◦ in 12 (28.5%) hips and above 30◦ in 11 hips (26.1%). In
tages III—IV, it was below 30◦ in 6 (14.2%) hips and above
0◦ in 13 hips (30.9%).
In the last assessment (13.4± 0.5 years), an index above
0◦ was a severity factor. Comparing the Index of Koo and
im in the non-operated group to the operated group, in
erms of ONFH staging, signiﬁcant degradation was evident
n the non-operated versus the operated group (p = 0.002).
atient satisfaction
orbidity was absent in our series (no hematoma, infection,
emoral neck fracture initiated by the drilling hole). In the
on-operated group, three out of 16 (18.7%) patients were
‘very satisﬁed to satisﬁed’’, while 13 out of 16 (81.3%) were
‘hardly satisﬁed or unsatisﬁed’’. In the operated patient
roup, 15 out of 26 (57.7%) patients were ‘‘very satisﬁed or
atisﬁed’’, and 11 (42.3%) were ‘‘hardly satisﬁed or unsatis-
ed’’. The difference was signiﬁcant in patients treated by
rilling (p = 0.02).
t
d
n
o
tat 3 years (B); total right hip prosthesis at 8 years post-core
iscussion
he difference in follow-up duration for the two
roups (13.4± 0.5 years for the non-operated group
nd 11.3± 1.8 years for the operated group) was not
tatistically signiﬁcant. Given the bias in recruitment of our
atients, we veriﬁed that the groups were similar and had
he same length of follow-up (Table 1). In the non-operated
roup, temporary discharge of 2 to 3months was difﬁcult
premature discontinuation of 1 or both canes), if not
mpossible for patients to follow in case of bilateral lesions.
valuation of pain and MAP scores
y comparing the two groups, the decompression achieved
ith drilling would explain the antalgic effect and improve-
ent of joint function in the operated group (p < 0.0001),
NFH accompanying stasis and intracapital hyperpressure
henomena responsible for pain. Decompression in the
emoral head by drilling would account for the rapid antalgic
utcome and the stoppage of hip function degradation
12,20,22—24].
valuation of necrotic lesions
he time to diagnosis of ONFH in the two groups could
e explained by the under-evaluation of signs indicating
ip pain or by accessibility to complementary examinations
TDM, MRI) of patients, with repetition of these tests inves-
igating lesion evolution. Furthermore, drepanocytosis, a
isease of pain, makes it difﬁcult to differentially diag-
ose the pain of ‘‘drepanocytic crises’’ or ‘‘the beginning
f hip necrosis’’ [3,15]. Repeated complementary examina-
ions deﬁned the evolutive character of the necrotic lesions.
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Figure 4 Patient with genotype SS aged 16 years with a right
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istage III ONFH treated by core decompression (A). Favorable
evolution with reconstruction of the right femoral head at 3
years (B).
The concept of evolution remains vital in the deﬁnition of
drepanocytic ONFH and indication of drilling [3]. The time
to diagnosis between groups was 3.5months (p < 0.001). The
shorter time period in the non-operated group could have
been due to easier access to complementary examinations
(TDM or MRI), for these patients with heavy medical histories
and frequent or post-partum hospitalizations.
Simple drilling would produce greater improvement of
necrotic lesions than surgical abstention. This beneﬁt of
drilling was noted by Bellot et al. [23]. ONFH operated in
stages I and II remained stable after drilling without requir-
ing arthroplasty (failure of drilling, p = 0.0001). A positive
evolution was also reported by Styles and Vichinsky [7], in
their series of 13 hips with a follow-up duration of 3 to
5 years. In addition to the indolence caused by decompres-
sion, the beneﬁt of drilling was manifested by lengthening
the time to arthroplasty (difference of 4.8 years, p < 0.01) in
favor of the operated group, a signiﬁcant difference which
conﬁrmed interest in the drilling technique. Given the fre-
quency and severity of total hip prosthesis complications in
drepanocytic patients, it would be desirable to undertake
screening for an early diagnosis of necrosis, beginning with
a simple surgical intervention (drilling) before considering
arthroplasty [7].
Two cases of stage III ONFH (osteochondritis of the
femoral head and necrosis with sub-chondral dissection)
were improved without loss of sphericity (Fig. 4A, B).
This reversibility of the lesions, after treatment, has been
reported by Chung et al. [5] and Hernigou et al. [25]. The
tunnel drilled, open after ablation of the core bipopsy spec-
imens, would serve as an outlet for decompression of the
femoral head [12,22]. It would promote the colonization of
conjunctive tissue, favorable to neovascularization of the
femoral head by vessels of the peritrochanteric region. This
neovascular theory [12] would explain the repair of bone
i
a
y
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esions observed in our study. Osteocondensation images
ere considered as stages of wound-healing of medullary
ecrosis, translating to non-evolving ONFH. They were the
esult of repetitive ischemic characteristics.
valuation according to the Koo and Kim Index
s in the study by Hernigou and Lambotte [26], the Koo and
im Index was a signiﬁcant factor of lesion degradation. It
as more signiﬁcant in the non-operated than in the oper-
ted group in our series. Failure of drilling was assessed by
rosthetic revision (with its time of occurrence [23].
atient satisfaction
imple and effective drilling and the long time period
efore eventual arthroplasty may explain the satisfaction
f operated group patients and permit better acceptance
f reintervention in drepanocytic patients often anguished
hen confronted by the risks of a major surgeries [27].
ip arthroplasty
ince the last 10 years, progress in anaesthesia and better
edical care of the disease have made it possible to oper-
te on drepanocytic patients under better conditions and to
mprove the results of hip arthroplasties (immediate indo-
ence with enhanced prosthesis survival from 5 to 15 years).
evertheless, the systematic use of total hip arthroplasty
ust be tempered by per- and postoperative difﬁculties
nd complications [11,28]. In fact, Hernigou et al. [28]
ave reported that, out of 312 arthroplasties performed in
44 drepanocytic patients (average age: 32 years, average
ollow-up 13 years), 3% were revised because of infection,
7% because of medical complications and 13% because of
ostoperative orthopaedic complications. Considering the
requency of these complications, it is desirable to estab-
ish early screening of ONFH to achieve a simple surgical act
drilling) — to limit the use of arthroplasty [7,9,22]
onclusions
ischarge in the treatment of ONFH in drepanocytic adults
ay not be recommended because, to be effective, the pro-
edure must be followed for 2 to 3months, which is difﬁcult,
f not impossible, for patients with bilateral lesions.
Radiological and clinical developments have shown that
rilling undertaken in the early stages of ONFH can stop the
volution towards debilitating arthrosis with some efﬁcacy
n stage I and II ONFH. It retains limited efﬁcacy, both imme-
iate and long-term, in stage III ONFH. Advanced staging
nd necrosis spreading must be well-described as they are
riteria of the prognostic evolution after drilling.
If well done, this intervention requires brief hospital-
zation, causes no particular morbidity, and respects hip
ntegrity in case of a new intervention. It is considered as
success if it allows arthroplasty to be deferred for a few
ears.
Given the fragility of sickle cell disease patients and
he immediate (infection, luxation) or late (infectious or
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echanical loosening) complications of hip prostheses, we
ecommend early screening of ONFH lesions for treatment
y a simple act, that is, drilling, before considering arthro-
lasty.
This simple drilling technique retains its place in the
reatment of sickle cell ONFH. It would be feasible in
nder-equipped regions where drepanocytosis and its osteo-
rticular complications are frequent. In the absence of
RI (diagnosis of pre-radiological or stage I ONFH), physi-
ians and surgeons could resort to simple tomography or
DM. To record bone pressure in the femoral trochanteric
ass, independently of a surgical intervention, under
ocal anaesthesia, manometry could conﬁrm the diagnosis
f early-stage osteonecrosis. These three complementary
xplorations (bone pressure measurement, tomography or
DM) would permit screening and effective treatment, by
rilling, of sickle cell necrotic lesions before the loss of
phericity or the occurrence of sub-chondral dissection.
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